NO20006572L - Medikamenter inneholdende bisfosfonsyrer og deres derivater for forhindring og behandling av autoimmune sykdommer og allergier - Google Patents

Medikamenter inneholdende bisfosfonsyrer og deres derivater for forhindring og behandling av autoimmune sykdommer og allergier

Info

Publication number
NO20006572L
NO20006572L NO20006572A NO20006572A NO20006572L NO 20006572 L NO20006572 L NO 20006572L NO 20006572 A NO20006572 A NO 20006572A NO 20006572 A NO20006572 A NO 20006572A NO 20006572 L NO20006572 L NO 20006572L
Authority
NO
Norway
Prior art keywords
acid
derivatives
bisphosphonic
autoimmune diseases
bisphosphonic acids
Prior art date
Application number
NO20006572A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006572D0 (no
Inventor
Hassan Jomaa
Original Assignee
Hassan Jomaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassan Jomaa filed Critical Hassan Jomaa
Publication of NO20006572D0 publication Critical patent/NO20006572D0/no
Publication of NO20006572L publication Critical patent/NO20006572L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20006572A 1998-06-26 2000-12-21 Medikamenter inneholdende bisfosfonsyrer og deres derivater for forhindring og behandling av autoimmune sykdommer og allergier NO20006572L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19828450A DE19828450A1 (de) 1998-06-26 1998-06-26 Bisphosphonsäuren und deren Derivate enthaltende Arzneimittel zur Prophylaxe und zur Behandlung von Autoimmunkrankheiten sowie von Allergien
PCT/DE1999/001844 WO2000000182A2 (de) 1998-06-26 1999-06-24 Bisphosphonsäuren und deren derivate enthaltende arzneimittel zur prophylaxe und zur behandlung von autoimmunkrankheiten sowie von allergien

Publications (2)

Publication Number Publication Date
NO20006572D0 NO20006572D0 (no) 2000-12-21
NO20006572L true NO20006572L (no) 2001-02-21

Family

ID=7872064

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006572A NO20006572L (no) 1998-06-26 2000-12-21 Medikamenter inneholdende bisfosfonsyrer og deres derivater for forhindring og behandling av autoimmune sykdommer og allergier

Country Status (24)

Country Link
EP (1) EP1089761B1 (xx)
JP (1) JP2002519319A (xx)
KR (1) KR20010053211A (xx)
AT (1) ATE224734T1 (xx)
AU (1) AU740605B2 (xx)
CA (1) CA2334711C (xx)
DE (2) DE19828450A1 (xx)
DK (1) DK1089761T3 (xx)
EA (1) EA200100080A1 (xx)
EE (1) EE200000756A (xx)
ES (1) ES2184496T3 (xx)
HR (1) HRP20000820A2 (xx)
HU (1) HUP0102873A3 (xx)
ID (1) ID27515A (xx)
IL (1) IL139966A0 (xx)
IS (1) IS5748A (xx)
MX (1) MXPA00012338A (xx)
NO (1) NO20006572L (xx)
NZ (1) NZ509505A (xx)
PL (1) PL345287A1 (xx)
PT (1) PT1089761E (xx)
SK (1) SK19602000A3 (xx)
TR (1) TR200003821T2 (xx)
WO (1) WO2000000182A2 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU754862B2 (en) * 1998-12-23 2002-11-28 Bioagency Ag Use of bisphosphonates for the prevention and treatment of infectious processes
WO2000038693A1 (fr) * 1998-12-25 2000-07-06 Toray Industries, Inc. Inhibiteurs de la production d'interleukine-6
DE20106394U1 (de) 2001-04-11 2001-08-09 Helm Pharmaceuticals Gmbh Pharmazeutische Zubereitung
ATE330616T1 (de) * 2001-05-02 2006-07-15 Novartis Pharma Gmbh Verabreichung von bisphosphonaten durch inhalation zur behandlung von knochenresorption und osteoporosis
PT1408984E (pt) 2001-07-20 2008-12-26 Bioagency Ag Compostos organofosforosos para activar células t gama/delta
GB0307989D0 (en) * 2003-04-07 2003-05-14 Mcewen Lab Ltd Therapeutic composition
DE602005025977D1 (de) * 2004-08-23 2011-03-03 Teva Pharma Kristalline form des ibandronat-natriums und herstellungsverfahren dafür
KR20080042131A (ko) * 2005-09-12 2008-05-14 닥터 레디스 레보러터리즈 리미티드 졸레드론산의 결정성 삼수화물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993005052A1 (fr) * 1991-09-05 1993-03-18 Toray Industries, Inc. Derive d'acide methanediphosphonique, sa production et son utilisation comme remede
WO1996022790A1 (en) * 1995-01-23 1996-08-01 Xenotech Incorporated Composition to ameliorate osteolysis and metastasis

Also Published As

Publication number Publication date
NO20006572D0 (no) 2000-12-21
PT1089761E (pt) 2003-02-28
WO2000000182A2 (de) 2000-01-06
CA2334711C (en) 2006-12-05
HRP20000820A2 (en) 2001-12-31
NZ509505A (en) 2002-11-26
ATE224734T1 (de) 2002-10-15
ES2184496T3 (es) 2003-04-01
SK19602000A3 (sk) 2001-07-10
EP1089761A2 (de) 2001-04-11
ID27515A (id) 2001-04-12
MXPA00012338A (es) 2003-04-25
DK1089761T3 (da) 2003-02-03
TR200003821T2 (tr) 2001-06-21
AU5503399A (en) 2000-01-17
DE59902856D1 (de) 2002-10-31
PL345287A1 (en) 2001-12-03
EP1089761B1 (de) 2002-09-25
HUP0102873A3 (en) 2002-04-29
JP2002519319A (ja) 2002-07-02
EA200100080A1 (ru) 2001-06-25
KR20010053211A (ko) 2001-06-25
CA2334711A1 (en) 2000-01-06
HUP0102873A2 (hu) 2001-12-28
EE200000756A (et) 2002-04-15
DE19828450A1 (de) 1999-12-30
WO2000000182A3 (de) 2000-03-30
IS5748A (is) 2000-12-01
AU740605B2 (en) 2001-11-08
IL139966A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
HK1072539A1 (en) Use of bisphosphonates in the preparation of a medicament for the treatment of conditings of abnormally increased bone turnover
BR0315328A (pt) Método de administração de bisfosfonatos
ATE249422T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
TW200640486A (en) Composition
BR0107755A (pt) Composição parenteral, processo para preparação e utilização dessa composição, processo para o tratamento e prevenção de enfermidades que, envolvem ressorção óssea e dispositivo para liberação local e sistêmica sustentada
BRPI0607549A2 (pt) sistemas de distribuição farmacêutica para fármacos hidrófobos e composições compreendendo os mesmos
NZ527157A (en) Compositions for delivering bisphosphonates
HRP20080612T3 (en) Combination of tenofovir, ritonavir and tmc114
BR0209875A (pt) Materiais de restauração dentária
NO20006572L (no) Medikamenter inneholdende bisfosfonsyrer og deres derivater for forhindring og behandling av autoimmune sykdommer og allergier
BG100911A (en) Biophosphonic acids-sontaining wet-granulated form
HUP0500039A2 (hu) Vakcina és eljárás mozgatóneuron-betegségek kezelésére
JO2663B1 (en) Abandronate is a large dose
DK1079849T3 (da) Anvendelse af HMG-proteiner til fremstilling af lægemidler med cytotoksisk virkning
HUP0202931A2 (hu) Egy gyógyszerészetileg hatásos összetétel és a beadására szolgáló készülék
ATE446763T1 (de) Pharmazeutische formulierung zur behandlung von osteoarthritis mit clodronsäure und hyaluronsäure
MX2022005044A (es) Formulacion de anticuerpo que contiene crizanlizumab.
Negi et al. Enhancing safety and efficacy of bisphosphonate therapy by association with hydroxyapatite as adjuvant drug carriers
ATE424399T1 (de) Pharmazeutische zusammensetzungen von risperidon in wässriger lösung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application